Serotonin Regulates Lipogenesis and Endoplasmic Reticulum Stress in Alcoholic Liver Disease

Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B...

Full description

Saved in:
Bibliographic Details
Published inDiabetes & metabolism journal Vol. 49; no. 4; pp. 798 - 811
Main Authors Hwang, Inseon, Nam, Jung Eun, Choi, Wonsuk, Choi, Won Gun, Lee, Eunji, Kim, Hyeongseok, Moon, Young-Ah, Park, Jun Yong, Kim, Hail
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Diabetes Association 01.07.2025
대한당뇨병학회
Subjects
Online AccessGet full text
ISSN2233-6079
2233-6087
2233-6087
DOI10.4093/dmj.2024.0215

Cover

Abstract Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.Methods: Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.Results: Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.Conclusion: GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD.
AbstractList Background Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood. Methods Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation. Results Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver-specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model. Conclusion GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD.
Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.BackgroundSerotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.MethodsBlood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.ResultsBlood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD.ConclusionGDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD.
Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood.Methods: Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation.Results: Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model.Conclusion: GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD. KCI Citation Count: 0
Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to regulate various biological processes in liver, direct role of 5-HT and its receptors, especially 5-HT receptor 2A (HTR2A) and HTR2B, in development and progression of alcoholic liver disease (ALD) in vivo is not well understood. Blood 5-HT level was measured from both human ALD patients and ethanol (EtOH) diet-fed mouse models. Gut-specific tryptophan hydroxylase 1 (Tph1) knockout mice, liver-specific Htr2a knockout mice, and liver-specific Htr2b knockout mice were fed with EtOH diet. Then we evaluated liver damage, hepatic steatosis, endoplasmic reticulum (ER) stress, and inflammation. Blood 5-HT concentrations are increased in both humans and mice with ALD. Both gut-specific Tph1 knockout and liver- specific Htr2a knockout mice are resistant to steatosis by down-regulating lipogenic pathways in liver of chronic EtOH diet-fed mice. Moreover, genetic inhibition of both gut-derived serotonin (GDS) synthesis and hepatic HTR2A signaling prevents ER stress in liver of chronic EtOH diet-fed mice. Additionally, we found that ablation of HTR2A signaling protects against disease progression by attenuating liver injury and inflammation in chronic plus binge EtOH diet-fed mice. Also, inhibiting HTR2A signaling ameliorates alcohol-induced liver injury and ER stress in an acute EtOH diet-fed mice model. GDS directly regulates lipogenesis and ER stress via signaling through hepatic HTR2A in the context of ALD. Inhibiting HTR2A signaling protects against alcohol-induced steatosis, liver injury and disease progression in various ALD mouse models and may also provide a novel therapeutic strategy for ALD.
Author Kim, Hail
Choi, Wonsuk
Hwang, Inseon
Nam, Jung Eun
Lee, Eunji
Kim, Hyeongseok
Park, Jun Yong
Choi, Won Gun
Moon, Young-Ah
Author_xml – sequence: 1
  givenname: Inseon
  orcidid: 0009-0006-5191-4525
  surname: Hwang
  fullname: Hwang, Inseon
– sequence: 2
  givenname: Jung Eun
  orcidid: 0000-0002-7021-8406
  surname: Nam
  fullname: Nam, Jung Eun
– sequence: 3
  givenname: Wonsuk
  surname: Choi
  fullname: Choi, Wonsuk
– sequence: 4
  givenname: Won Gun
  surname: Choi
  fullname: Choi, Won Gun
– sequence: 5
  givenname: Eunji
  surname: Lee
  fullname: Lee, Eunji
– sequence: 6
  givenname: Hyeongseok
  surname: Kim
  fullname: Kim, Hyeongseok
– sequence: 7
  givenname: Young-Ah
  surname: Moon
  fullname: Moon, Young-Ah
– sequence: 8
  givenname: Jun Yong
  orcidid: 0000-0001-6324-2224
  surname: Park
  fullname: Park, Jun Yong
– sequence: 9
  givenname: Hail
  orcidid: 0000-0002-6652-1349
  surname: Kim
  fullname: Kim, Hail
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39905656$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003222188$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNpVkk1rGzEQhkVJaT6aY69lj6VgV99anYpJ0tRgKCTpqQehlbSOHK3kSruB_vvKdmoaXUbMPPOOxLzn4CSm6AD4gOCcQkm-2GEzxxDTOcSIvQFnGBMy47AVJ8e7kKfgspQNrIe2UAj5DpwSKSHjjJ-BX_cupzFFH5s7t56CHl1pVn6b1i664kujo21uok3boMvgTaVGb6YwDc39mF0pTe1cBJMeU6jVlX92ubn2xeni3oO3vQ7FXb7EC_Dz283D1ffZ6sft8mqxmhnCMZu1naailbTtCCOGCEGR6YyUfc-YMZYYqHVHuEGaWEOolJoirplwvKVM9ppcgM8H3Zh79WS8Strv4zqpp6wWdw9LhaAgmBFR4eUBtklv1Db7Qec_-459IuW10rl-MThlieSitcj2oo6UuLXW8g4i2UnuqGBV6-tBazt1g7PGxTHr8Er0dSX6x_qoZ4UwFnUBsip8elHI6ffkyqgGX4wLQUeXpqII4oTt9gYr-vH_Yccp_3ZZgdkBMDmVkl1_RBBUO7uoahe1s4va2YX8BZ8Wsf0
Cites_doi 10.1111/j.1365-2982.2009.01370.x
10.1016/s0140-6736(09)60746-7
10.1016/s0016-5085(03)00276-2
10.1038/s41598-018-36097-6
10.1002/hep.26419
10.1111/j.1440-1746.2007.05276.x
10.1155/2012/479348
10.1016/j.tips.2018.03.004
10.1385/mn:29:1:31
10.1002/hep.23258
10.1155/2014/513787
10.1016/j.jhep.2013.03.007
10.1038/nprot.2013.032
10.1038/nm1780
10.1111/j.1463-1326.2011.01378.x
10.1126/science.1123842
10.1097/01.alc.0000174691.03751.11
10.1126/science.1097540
10.1038/nm.2490
10.1016/j.cmet.2012.09.014
10.1055/s-0039-1681032
10.1038/nature09968
10.1038/ncomms7794
10.1038/s41572-018-0014-7
10.1053/j.gastro.2011.09.002
10.1002/hep.24368
10.1146/annurev.med.60.042307.110802
10.1053/j.gastro.2004.09.049
10.1056/nejmra0805786
10.1038/s41467-022-35069-9
10.1016/j.cell.2008.09.059
10.3389/fimmu.2023.1184010
10.1002/hep.23382
10.1042/bj20140881
10.1038/nm.2173
10.1038/s41467-018-07287-7
10.1016/j.jhep.2010.11.005
10.1152/ajpgi.00542.2004
10.1074/jbc.m202411200
10.1073/pnas.1117792109
10.1126/science.1078197
10.1038/169800b0
10.1007/s11010-009-0142-1
ContentType Journal Article
Copyright Copyright © 2025 Korean Diabetes Association 2025
Copyright_xml – notice: Copyright © 2025 Korean Diabetes Association 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
ACYCR
DOI 10.4093/dmj.2024.0215
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2233-6087
EndPage 811
ExternalDocumentID oai_kci_go_kr_ARTI_10732537
oai_doaj_org_article_d39678d1df7a41928ddd6b019b96e475
PMC12270569
39905656
10_4093_dmj_2024_0215
Genre Journal Article
GroupedDBID 5-W
5VS
7RV
7X7
88E
8FI
8FJ
8JR
8XY
9ZL
AAYXX
ABDBF
ABUWG
ADBBV
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
DIK
EF.
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M1P
NAPCQ
O5R
O5S
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PSQYO
RPM
UKHRP
ADRAZ
CGR
CUY
CVF
ECM
EIF
IPNFZ
M48
NPM
RIG
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c3625-8ba478948b353c37741cbc99ff55ccd3c0aab36c1a3dc3499a416a57e68459fa3
IEDL.DBID DOA
ISSN 2233-6079
2233-6087
IngestDate Sun Jul 06 03:13:48 EDT 2025
Wed Aug 27 01:31:39 EDT 2025
Thu Aug 21 18:25:44 EDT 2025
Thu Sep 04 21:47:26 EDT 2025
Sun Jul 20 01:30:34 EDT 2025
Sun Aug 03 02:34:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Tryptophan hydroxylase
Fatty liver
Liver diseases
Serotonin
Alcoholics
Receptors, serotonin
Endoplasmic reticulum stress
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3625-8ba478948b353c37741cbc99ff55ccd3c0aab36c1a3dc3499a416a57e68459fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Inseon Hwang and Jung Eun Nam contributed equally to this study as first authors.
ORCID 0000-0002-7021-8406
0009-0006-5191-4525
0000-0002-6652-1349
0000-0001-6324-2224
OpenAccessLink https://doaj.org/article/d39678d1df7a41928ddd6b019b96e475
PMID 39905656
PQID 3163504800
PQPubID 23479
PageCount 14
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10732537
doaj_primary_oai_doaj_org_article_d39678d1df7a41928ddd6b019b96e475
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12270569
proquest_miscellaneous_3163504800
pubmed_primary_39905656
crossref_primary_10_4093_dmj_2024_0215
PublicationCentury 2000
PublicationDate 2025-07-01
PublicationDateYYYYMMDD 2025-07-01
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Diabetes & metabolism journal
PublicationTitleAlternate Diabetes Metab J
PublicationYear 2025
Publisher Korean Diabetes Association
대한당뇨병학회
Publisher_xml – name: Korean Diabetes Association
– name: 대한당뇨병학회
References ref13
ref35
ref12
ref34
ref15
ref37
ref14
ref36
ref31
ref30
ref11
ref33
ref10
ref32
ref2
ref1
ref17
ref39
ref16
ref38
ref19
ref18
Galli (ref8) 2001
ref24
ref23
ref26
ref25
ref20
ref42
ref41
ref22
ref44
ref21
ref43
ref28
ref27
ref29
ref7
ref9
ref4
ref3
ref6
ref5
ref40
References_xml – ident: ref18
  doi: 10.1111/j.1365-2982.2009.01370.x
– ident: ref1
  doi: 10.1016/s0140-6736(09)60746-7
– ident: ref14
  doi: 10.1016/s0016-5085(03)00276-2
– ident: ref34
  doi: 10.1038/s41598-018-36097-6
– ident: ref40
  doi: 10.1002/hep.26419
– ident: ref39
  doi: 10.1111/j.1440-1746.2007.05276.x
– ident: ref13
  doi: 10.1155/2012/479348
– ident: ref44
  doi: 10.1016/j.tips.2018.03.004
– ident: ref27
  doi: 10.1385/mn:29:1:31
– ident: ref9
  doi: 10.1002/hep.23258
– ident: ref12
  doi: 10.1155/2014/513787
– ident: ref2
  doi: 10.1016/j.jhep.2013.03.007
– ident: ref35
  doi: 10.1038/nprot.2013.032
– ident: ref32
  doi: 10.1038/nm1780
– ident: ref23
  doi: 10.1111/j.1463-1326.2011.01378.x
– ident: ref30
  doi: 10.1126/science.1123842
– ident: ref17
  doi: 10.1097/01.alc.0000174691.03751.11
– ident: ref20
  doi: 10.1126/science.1097540
– ident: ref33
  doi: 10.1038/nm.2490
– ident: ref25
  doi: 10.1016/j.cmet.2012.09.014
– start-page: 68
  volume-title: The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism: a novel mechanism for the development of ethanol-induced fatty liver
  year: 2001
  ident: ref8
– ident: ref11
  doi: 10.1055/s-0039-1681032
– ident: ref16
  doi: 10.1038/nature09968
– ident: ref26
  doi: 10.1038/ncomms7794
– ident: ref3
  doi: 10.1038/s41572-018-0014-7
– ident: ref4
  doi: 10.1053/j.gastro.2011.09.002
– ident: ref42
  doi: 10.1002/hep.24368
– ident: ref21
  doi: 10.1146/annurev.med.60.042307.110802
– ident: ref6
  doi: 10.1053/j.gastro.2004.09.049
– ident: ref10
  doi: 10.1056/nejmra0805786
– ident: ref36
  doi: 10.1038/s41467-022-35069-9
– ident: ref29
  doi: 10.1016/j.cell.2008.09.059
– ident: ref37
  doi: 10.3389/fimmu.2023.1184010
– ident: ref7
  doi: 10.1002/hep.23382
– ident: ref41
  doi: 10.1042/bj20140881
– ident: ref28
  doi: 10.1038/nm.2173
– ident: ref31
  doi: 10.1038/s41467-018-07287-7
– ident: ref43
  doi: 10.1016/j.jhep.2010.11.005
– ident: ref38
  doi: 10.1152/ajpgi.00542.2004
– ident: ref5
  doi: 10.1074/jbc.m202411200
– ident: ref24
  doi: 10.1073/pnas.1117792109
– ident: ref19
  doi: 10.1126/science.1078197
– ident: ref22
  doi: 10.1038/169800b0
– ident: ref15
  doi: 10.1007/s11010-009-0142-1
SSID ssj0000480779
Score 2.3600466
Snippet Background: Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is...
Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is known to...
Background Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine neurotransmitter that has various functions in central and peripheral tissues. While 5-HT is...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 798
SubjectTerms alcoholics
Animals
Disease Models, Animal
endoplasmic reticulum stress
Endoplasmic Reticulum Stress - drug effects
Endoplasmic Reticulum Stress - physiology
fatty liver
Female
Humans
Lipogenesis - drug effects
Lipogenesis - physiology
Liver - metabolism
Liver - pathology
liver diseases
Liver Diseases, Alcoholic - blood
Liver Diseases, Alcoholic - genetics
Liver Diseases, Alcoholic - metabolism
Liver Diseases, Alcoholic - pathology
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Original
Receptor, Serotonin, 5-HT2A - genetics
Receptor, Serotonin, 5-HT2A - metabolism
Receptor, Serotonin, 5-HT2B - genetics
Receptor, Serotonin, 5-HT2B - metabolism
receptors, serotonin
serotonin
Serotonin - blood
Serotonin - metabolism
tryptophan hydroxylase
Tryptophan Hydroxylase - genetics
Tryptophan Hydroxylase - metabolism
내과학
Title Serotonin Regulates Lipogenesis and Endoplasmic Reticulum Stress in Alcoholic Liver Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/39905656
https://www.proquest.com/docview/3163504800
https://pubmed.ncbi.nlm.nih.gov/PMC12270569
https://doaj.org/article/d39678d1df7a41928ddd6b019b96e475
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003222188
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Diabetes and Metabolism Journal, 2025, 49(4), 210, pp.798-811
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9QwDLdgSIgXxPjsxk5FIN7K2ub7cWM3DdgmGEw6iYcoTdJRprWnu9v_j5Pcpjs0iRdeWqlJWtdu7Z_jxAZ4RzkvRWsRualWFVS4ulCEmwL1cQjEiJbHqYGTU350Tj9P2GSl1FdYE5bSAyfG7TqiUJ-6yrXChIildM7xBoFJo7inImYvLVW54kxFHRx2SsdEe2j-SIH0qJRgE90ZsuuufqNnWNMPweCtGaSYtx_NTD9r74Kcf6-cXDFFh0_g8RJD5nuJ9k245_un8PBkGSV_Bj9RAQyLMM-an6VS836eH3fT4SIotm6em97l494NU4TOV53FXos0DZh_j1tHchy5l2rnYutxWLqRH6RIznM4Pxz_-HhULIsoFBZtEytkY6iQisqGMGIJor3KNlaptmXMWkdsaUxDuK0McZag_4Nc5oYJzyVlqjXkBWz0Q-9fQV4ZlINlFXeupp5I6YnFX5hXjtQG75PB-xtO6mnKlaHRxwgs18hyHViuA8sz2A98vu0UUlzHCyh4vRS8_pfgM3iLUtKXtovjw_li0JczjY7AJ3yuIDUjIoM3N1LU-OOEaIjp_XA910g4YeE7KTN4maR6SxCitjIg3QzkmrzXKF5v6btfMTl3VdcCx6qt__GO2_CoDvWG4_Lg17CxmF37HQRBi2YE98VEjODB_vj069kofv14_PJN_gG0KwX8
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serotonin+Regulates+Lipogenesis+and+Endoplasmic+Reticulum+Stress+in+Alcoholic+Liver+Disease&rft.jtitle=Diabetes+%26+metabolism+journal&rft.au=Hwang%2C+Inseon&rft.au=Nam%2C+Jung+Eun&rft.au=Choi%2C+Wonsuk&rft.au=Choi%2C+Won+Gun&rft.date=2025-07-01&rft.pub=Korean+Diabetes+Association&rft.issn=2233-6079&rft.eissn=2233-6087&rft.volume=49&rft.issue=4&rft.spage=798&rft.epage=811&rft_id=info:doi/10.4093%2Fdmj.2024.0215&rft_id=info%3Apmid%2F39905656&rft.externalDocID=PMC12270569
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2233-6079&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2233-6079&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2233-6079&client=summon